Business Operations Manager, Therapeutics & Innovations
Natera- Full Time
- Junior (1 to 2 years)
Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks. With their purified, high-precision investigational cell therapies, they aim to not only replace patients' blood and immune systems with healthy ones but also restore their lives.
The Cell Therapy Platform Lead will head the strategy, development, and implementation of Orca Bio’s digital ordering and coordination platform, ensuring it effectively supports key customer workflows such as ordering, scheduling, and delivery. This role serves as the business owner of the platform, driving cross-functional collaboration, managing project execution and budget, and ensuring alignment with customer needs and internal processes. This function will also oversee the end-to-end experience of the customer in using and adopting the platform, lead feedback-driven improvements, and implement tools and training to enhance customer support, usability, and satisfaction. A seamless, customer-centric platform experience relies on strong customer engagement, effective integration with business processes, high platform performance, and scalable infrastructure.
Develops and commercializes cell therapies
Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.